Bio-Gate H1 EBIT loss widens 10% to EUR 927,000; revenue drops 18% to EUR 2.8 million

PUBT · 1d ago
Bio-Gate H1 EBIT loss widens 10% to EUR 927,000; revenue drops 18% to EUR 2.8 million
  • Bio-Gate posted H1 2026 revenue of EUR 2.8 million, down 18% year over year.
  • EBIT loss widened to EUR 927,000, while the company said cost cuts and efficiency measures reduced losses relative to the revenue drop.
  • Lower call-off volumes from two large human and animal care customers followed portfolio changes and organizational shifts, hitting derma-cosmetics and wound care.
  • Veterinary and measurement services lifted their revenue contributions, while medical technology lagged expectations on milestone timing shifts tied to delayed partner deliveries.
  • 2026 outlook cut to revenue of EUR 6.0 million-EUR 6.9 million; EBIT seen at a loss of EUR 1.1 million-EUR 1.5 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Gate AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2413462_de) on October 09, 2026, and is solely responsible for the information contained therein.